Comparison of the Nociception Monitoring Devices During Cardiac Surgery.
SYDNOS
1 other identifier
interventional
40
1 country
1
Brief Summary
The purpose of this study is to compare the values of Surgical Pleth Index (SPI) and Nociception Level Index (NOL) measured simultaneously during cardiac surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Feb 2021
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 21, 2020
CompletedFirst Posted
Study publicly available on registry
January 15, 2021
CompletedStudy Start
First participant enrolled
February 22, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2025
CompletedMarch 6, 2025
March 1, 2025
4 years
December 21, 2020
March 4, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
SPI values measured at several timepoints during cardiac surgery
SPI (Surgical Pleth Index) - index measuring nociceptive response based on pulse and pulse amplitude.
Values are measured during the course of the cardiac surgery procedure
NOL values measured at several timepoints during cardiac surgery
NOL (Nociception Level Index) - nociception index based on heart rate and its changes, pulse wave amplitude, skin impedance and its changes, temperature and their variations
Values are measured during the course of the cardiac surgery procedure
Study Arms (1)
Cardiac surgery patients
OTHERPatients scheduled for elective cardiac surgery (CABG or valve surgery).
Interventions
Patient is connected to non-invasive PMD-200 monitor, measuring Nociception Level
Patient is connected to non-invasive monitor measuring Surgical Pleth Index
Eligibility Criteria
You may qualify if:
- coronary artery disease of heart valve disorder qualified for the surgical treatment
- participant understands the course of the trial and its aim
- participant has given informed written consent
You may not qualify if:
- participant has not given consent
- neurological or psychical disorders (psychiatric medication)
- dementia
- alcohol or substance abuse
- central nervous system medication (medication for epilepsy or neuropathic pain)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Kuopio University Hospital
Kuopio, Northern Savonia, 70029, Finland
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Tadeusz Musialowicz, PhD, MD
Kuopio University Hospital, Department of Anesthesiology and Intensive Care
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 21, 2020
First Posted
January 15, 2021
Study Start
February 22, 2021
Primary Completion
March 1, 2025
Study Completion
March 1, 2025
Last Updated
March 6, 2025
Record last verified: 2025-03
Data Sharing
- IPD Sharing
- Will not share